Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
R.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
R.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.216NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.216NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.216NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.471NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17944.4US
B.1.471NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.471NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16604.2China
C.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.420NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.420NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.420NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
L.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
L.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
L.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.518NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.518NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.518NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.551NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.551NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.551NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.207NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.207NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.207NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.604NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.604NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.604NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.111NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.111NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.111NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.619NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.619NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.619NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.36.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.36.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.36.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.36.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.23.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.23.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.23.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used